19 May 2015, 6:30 am
Intertwining health problems – syndemics – are associated with higher viral load and poorer adherence in HIV-positive men who have sex with men (MSM) taking antiretroviral treatment (ART), investigators from the United States report in the online edition of AIDS. “Higher HIV viral load and lower ART adherence are, respectively, associated with increased syndemics count,” explain

17 May 2015, 7:10 am
Civacir, a hepatitis C immune globulin or antibody product, reduced the likelihood of hepatitis C virus infecting the new liver graft after transplantation in people who were receiving, but had not yet completed, antiviral treatment, according to preliminary study findings presented at the European Association for the Study of the Liver (EASL) 50th International Liver

15 May 2015, 8:40 am
A six-week regimen of sofosbuvir (Sovaldi) plus two experimental direct-acting antivirals being developed by Gilead Sciences cured more than 90% of previously untreated people with genotype 1 hepatitis C virus and no liver cirrhosis, according to a poster presentation at the European Association for the Study of the Liver (EASL) 50th International Liver Congress last

15 May 2015, 7:20 am
Shortening hepatitis C treatment to 6 weeks for easier-to-treat patients without cirrhosis does not greatly reduce the efficacy of hepatitis C treatment for people with genotype 1 infection, according to results of a study combining grazoprevir, elbasvir and sofosbuvir in short treatment courses. Moreover the study showed that for people with genotype 3 hepatitis C but

14 May 2015, 8:20 am
Treatment with tenofovir/emtricitabine (Truvada) as pre-exposure prophylaxis (PrEP) is associated with small but significant decreases in bone mineral density (BMD), investigators from the landmark iPrEx study report in the online edition of Clinical Infectious Diseases. Changes in bone mineral density were compared between people randomised to receive Truvada and individuals in the control arm. Treatment with Truvada

1 2

    • No upcoming events
  • View All Add your news